Practice Management
Feature
From Scrubs to Social Media: How Some Med Students Become Influencers
Med students discussed why and how frequently they post on social media.
Feature
Patient Navigators for Serious Illnesses Can Now Bill Under New Medicare Codes
New Medicare codes will enable physicians to hire navigators to help patients manage serious illnesses such as cancer and heart failure.
Latest News
No Surprises Act: Private Equity Scores Big in Arbitrations
Private equity–owned organizations are forcefully challenging insurers about payments for certain kinds of out-of-network care.
Commentary
Cancer Treatment 101: A Primer for Non-Oncologists
Doctor explains why he thinks time of diagnosis is the best time for molecular testing of a new malignant tumor.
Latest News
Physicians Lament Over Reliance on Relative Value Units: Survey
“The current RVU system encourages unnecessary procedures, hurting patients.”
Feature
Jeffrey Weber, MD, PhD, Giant of Cancer Care, Dies
He was a principal investigator on many studies, including pivotal clinical drug trials in melanoma.
Commentary
Low HPV Vaccination in the United States Is a Public Health ‘Failure’
For this vaccine, which is incredibly safe and incredibly effective, in this country, only 38.6% have received even a single dose.
Feature
Doctors Are Seeking Professional Coaches More Often. Here’s Why
More and more doctors are using professional coaching to manage life in medicine. The coaches, also physicians, say it might be a cure for burnout...
Feature
FTC Interim Report on Pharmacy Middlemen Is First Step of Many Needed in Addressing Drug Costs, Access
Madelaine Feldman, MD, has been a vocal PBM critic for years. She sees a recent FTC interim report as evidence of the need for congressional...
Commentary
What Would ‘Project 2025’ Mean for Health and Healthcare?
Conservative group–backed plan intends to alter the processes and/or funding of CDC, NIH, Medicaid, and other agencies.
News from the FDA/CDC
FDA Approves Lymphir for R/R Cutaneous T-Cell Lymphoma
The immunotherapy is a reformulation of denileukin diftitox that was initially approved for certain patients with persistent or recurrent...